Table: begin end state 1 20 cytoplasmic 21 47 transmembrane 48 59 non-cytoplasmic 60 82 transmembrane 83 89 cytoplasmic 90 110 transmembrane 111 116 non-cytoplasmic 117 137 transmembrane 138 148 cytoplasmic 149 172 transmembrane 173 177 non-cytoplasmic 178 199 transmembrane 200 258 cytoplasmic 259 282 transmembrane 283 297 non-cytoplasmic 298 318 transmembrane 319 328 cytoplasmic 329 360 transmembrane 361 384 non-cytoplasmic 385 405 transmembrane 406 415 cytoplasmic 416 434 transmembrane 435 465 non-cytoplasmic
Input: >WP_011382707.1 MTRDNQLNIQTFLNESRFSPYQWTVFALCFFVVLLDGFDTAAIGYIAPSLLKEWGIAKPA LGPVLSAALFGLAAGALSAGPLADRFGRRLVLTGSTLLFALASLASSFAGSLDGLTVLRF VTGIGLGAAMPNAVTLISEYCPDQRRSLLTNAMFAGFPLGAALGGFLAAWIIPQWGWRSV LVLGGIAPLALVALMAVSLPESIRYMVARRQPAERIRKVLSRISASAAQAQGFVMTEAAA KVAPTGKAGLGVVLSKSYLVGSVMMWLAYFMGLVIFYGLINWMPLLLKDAGLDPKSATLI SALFPLGGVGAIFFGWLMDRANGNKVIAAGYVLTALLIFAIGQAVGNVGVLVLLVLVAGT LMNTAQSSMPALAAGFYPTSGRATGVAWMLGMGRFGGIAGSTLVAELSRRQLGFSEMFTI IAIPGLIAAAALLVKQMAHPETPAEHDAAVGEAHEHAQEAQLGGH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server